Introduction

Osteoporosis is the most common metabolic bone disease worldwide and is characterised by low bone mass, changes in bone microarchitecture and deterioration of bone tissue.1

Learning objectives

After successful completion of this CPD activity, pharmacists should be able to:

  • Describe the pathophysiology of osteoporosis
  • Explain treatment options in the management of osteoporosis
  • Discuss the risk factors for osteoporosis
  • Discuss the role of the pharmacist in the management of osteoporosis.

Competency standards addressed (2016): 1.1, 1.2, 1.5, 2.4, 3.1

Osteoporosis
Supported by an unrestricted educational grant from Amgen. The authors received no funding from nor have any affiliations with the sponsor. Funding was provided retrospectively.

Already read the CPD in the journal? Scroll to the bottom to SUBMIT ANSWERS.

It was estimated that in 2012, 66% of Australians over 50 years of age had poor bone health either in the form of osteopenia or osteoporosis.2 This figure is estimated to in

THIS IS A CPD ARTICLE. YOU NEED TO BE A PSA MEMBER AND LOGGED IN TO READ MORE.